In vitro activity and in vivo efficacy of the saponin diosgenyl 2-amino-2-deoxy-b-d-glucopyranoside hydrochloride (HSM1) alone and in combination with daptomycin and vancomycin against Gram-positive cocci

Journal of Medical Microbiology

Volumn 60, Issue 9, 2011, Pages 1337-1343

  Cirioni, Oscar ^a   Myszka, Henryk ^b   Dawgul, Malgorzata ^c   Ghiselli, Roberto ^a   Orlando, Fiorenza ^d   Silvestri, Carmela ^a   Brescini, Lucia ^a   Kamysz, Wojciech ^c   Guerrieri, Mario ^a   Giacometti, Andrea ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF GDA SK   (Poland)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

^d INRCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DAPTOMYCIN; DIOSGENYL 2 AMINO 2 DEOXY BETA DEXTRO GLUCOPYRANOSIDE; DOXYCYCLINE; ERYTHROMYCIN; LINEZOLID; SAPONIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CONTROL GROUP; DRUG EFFICACY; ENTEROCOCCUS FAECALIS; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; WOUND INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; DAPTOMYCIN; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; GRAM-POSITIVE BACTERIAL INFECTIONS; GRAM-POSITIVE COCCI; MALE; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; RODENT DISEASES; SAPONINS; SURGICAL WOUND INFECTION; TREATMENT OUTCOME; VANCOMYCIN;

EID: 80051736586     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.031708-0     Document Type: Article

References (28)

1. Aremu, A. O., Fawole, O. A., Chukwujekwu, J. C., Light, M. E., Finnie, J. F. & Van Staden, J. (2010). In vitro antimicrobial, anthelmintic and cyclooxygenase-inhibitory activities and phytochemical analysis of Leucosidea sericea. J Ethnopharmacol 131, 22-27.
2. Bouza, E. (2009). New therapeutic choices for infections caused by methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 15 (Suppl. 7), 44-52.
3. Bratzler, D. W., Houck, P. M. For the Surgical Infection Prevention Guidelines Writers Workgroup (2004). Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 38, 1706-1715.
4. Burke, J. P. (2003). Infection control-a problem for patient safety. N Engl J Med 348, 651-656.
5. NCCLS (2003). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard. M7-A6. Villanova, PA: National Committee for Clinical Laboratory Standards.
6. Cormican, M. G. & Jones, R. N. (1996). Emerging resistance to antimicrobial agents in Gram-positive bacteria. Enterococci, staphylococci and nonpneumococcal streptococci. Drugs 51 (Suppl. 1), 6-12.
7. Datta, S., Maitra, S., Gayen, P. & Sinha Babu, S. P. (2009). Improved efficacy of tetracycline by acaciasides on Dirofilaria immitis. Parasitol Res 105, 697-702.
8. Di Liberto, M., Svetaz, L., Furlá n, R. L., Zacchino, S. A., Delporte, C., Novoa, M. A., Asencio, M. & Cassels, B. K. (2010). Antifungal activity of saponin-rich extracts of Phytolacca dioica and of the sapogenins obtained through hydrolysis. Nat Prod Commun 5, 1013-1018.
9. Eliopoulos, G. M. & Moellering, R. C., Jr (1996). Antimicrobial combinations. In Antibiotics in Laboratory Medicine, pp. 330-393. Edited by V. Lorian. Baltimore, MD: Williams & Wilkins.
10. Fisher, K. & Phillips, C. (2009). The ecology, epidemiology and virulence of Enterococcus. Microbiology 155, 1749-1757.
11. Grundmann, H., Aires-de-Sousa, M., Boyce, J. & Tiemersma, E. (2006). Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 368, 874-885.
12. Hirsch, T., Koerber, A., Jacobsen, F., Dissemond, J., Steinau, H. U., Gatermann, S., Al-Benna, S., Kesting, M., Seipp, H. M. & Steinstraesser, L. (2010). Evaluation of toxic side effects of clinically used skin antiseptics in vitro. J Surg Res 164, 344-350.
13. Kugelberg, E., Norströ m, T., Petersen, T. K., Duvold, T., Andersson, D. I. & Hughes, D. (2005). Establishment of a superficial skin infection model in mice by using Staphylococcus aureus and Streptococcus pyogenes. Antimicrob Agents Chemother 49, 3435-3441.
14. Linden, P. K. (1998). Clinical implications of nosocomial Grampositive bacteremia and superimposed antimicrobial resistance. Am J Med 104, 24S-33S.
15. Maviglia, R., Nestorini, R. & Pennisi, M. (2009). Role of old antibiotics in multidrug resistant bacterial infections. Curr Drug Targets 10, 895-905.
16. Moellering, Jr R. C., (1998). Problems with antimicrobial resistance in Gram-positive cocci. Clin Infect Dis 26, 1177-1178.
17. Myszka, H., Bednarczyk, D., Najder, M. & Kaca, W. (2003). Synthesis and induction of apoptosis in B cell chronic leukemia by diosgenyl 2-amino-2-deoxy-b-D-glucopyranoside hydrochloride and its derivatives. Carbohydr Res 338, 133-141.
18. Qi, X., Bakht, S., Qin, B., Leggett, M., Hemmings, A., Mellon, F., Eagles, J., Werck-Reichhart, D., Schaller, H. & other authors (2006). A different function for a member of an ancient and highly conserved cytochrome P450 family: from essential sterols to plant defense. Proc Natl Acad Sci U S A 103, 18848-18853.
19. Qiang, H., Zhang, C., Shi, Z.-B., Yang, H.-Q. & Wang, K.-Z. (2010). Protective effects and mechanism of Panax notoginseng saponins on oxidative stress-induced damage and apoptosis of rabbit bone marrow stromal cells. Chin J Integr Med 16, 525-530.
20. Raad, I., Alrahwan, A. & Rolston, K. (1998). Staphylococcus epidermidis: emerging resistance and need for alternative agents. Clin Infect Dis 26, 1182-1187.
21. Saleem, M., Nazir, M., Ali, M. S., Hussain, H., Lee, Y. S., Riaz, N. & Jabbar, A. (2010). Antimicrobial natural products: an update on future antibiotic drug candidates. Nat Prod Rep 27, 238-254.
22. Simonetti, O., Cirioni, O., Ghiselli, R., Goteri, G., Scalise, A., Orlando, F., Silvestri, C., Riva, A., Saba, V.other authors (2008). RNAIIIinhibiting peptide enhances healing of wounds infected with methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 52, 2205-2211.
23. Simons, V., Morrissey, J. P., Latijnhouwers, M., Csukai, M., Cleaver, A., Yarrow, C. & Osbourn, A. (2006). Dual effects of plant steroidal alkaloids on Saccharomyces cerevisiae. Antimicrob Agents Chemother 50, 2732-2740.
24. Spellberg, B., Guidos, R., Gilbert, D., Bradley, J., Boucher, H. W., Scheld, W. M., Bartlett, J. G., Edwards, J., Jr. Infectious Diseases Society of America (2008). The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 46, 155-164.
25. Sung, W. S. & Lee, D. G. (2008). The combination effect of Korean red ginseng saponins with kanamycin and cefotaxime against methicillinresistant Staphylococcus aureus. Biol Pharm Bull 31, 1614-1617.
26. Wallace, R. J. (2004). Antimicrobial properties of plant secondary metabolites. Proc Nutr Soc 63, 621-629.
27. Yang, C.-R., Zhang, Y., Jacob, M. R., Khan, S. I., Zhang, Y.-J. & Li, X.-C. (2006). Antifungal activity of C-27 steroidal saponins. Antimicrob Agents Chemother 50, 1710-1714.
28. Ying-Wan, Wu, Y.-L., Feng, X.-C., Lian, L.-H., Jiang, Y.-Z. & Nan, J.-X. (2010). The protective effects of total saponins from Ornithogalum saundersiae (Liliaceae) on acute hepatic failure induced by lipopolysaccharide and D-galactosamine in mice. J Ethnopharmacol 132, 450-455.